Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Care Services by Patients With Borderline Personality Disorder (EpiB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02829658
Recruitment Status : Completed
First Posted : July 12, 2016
Last Update Posted : May 12, 2017
Sponsor:
Information provided by (Responsible Party):
University Hospital, Toulouse

Tracking Information
First Submitted Date July 4, 2016
First Posted Date July 12, 2016
Last Update Posted Date May 12, 2017
Study Start Date February 2009
Actual Primary Completion Date June 2010   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 12, 2016)
Compare data among BPD Patients and general population [ Time Frame: during five years previously to the inclusion ]
Utilization of mental health care
Original Primary Outcome Measures
 (submitted: July 7, 2016)
Compare data among TBR Patients and general population [ Time Frame: during five years previously to the inclusion ]
Utilization of mental health care
Change History Complete list of historical versions of study NCT02829658 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures
 (submitted: July 12, 2016)
  • Hospitalizations [ Time Frame: During five years previously to the inclusion ]
    Compare hospitalizations between BPD patients and general population
  • Demographics data [ Time Frame: Inclusion ]
    Compare demographic data between BPD patient and general population
Original Secondary Outcome Measures
 (submitted: July 7, 2016)
  • Hospitalizations [ Time Frame: During five years previously to the inclusion ]
    Compare hospitalizations between TBR patients and general population
  • Demographics data [ Time Frame: Inclusion ]
    Compare demographic data between TBR patient and general population
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Use of Care Services by Patients With Borderline Personality Disorder
Official Title Use of Care Services by Patients With Borderline Personality Disorder
Brief Summary

Borderline personality disorder (BPD) is characterized by a pervasive pattern of instability and impulsivity. Several North American prospective studies support the high level of mental health care utilization in this population. There is little data in other systems of health organization, such as France. Furthermore, little is known on the variables associated with the mental health service utilization among BPD patients.

The main objective was to compare the utilization of mental health care among BPD patients, to the general population and patients with another personality disorder (PD) and to describe the demographic and clinical factors associated with the group of patients who use the most health care.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population First, four groups were composed: BPD, other PD, control groups for PD and other PD. The first two groups were recruited from a screening of inpatients including a self-administered questionnaire (Personality Disorder Questionnaire 4+). Matched controls (age, sex) composed the 3rd and 4th group (BPD control and other PD control). They were randomly chosen in the health database insurance previously used.
Condition Borderline Personality Disorder
Intervention
  • Behavioral: Psychologic test
    Assessment by a psychologist including the Structured Interview for Diagnostic and Statistical Manual (DSM)-IV Personality Disorders (SIDP-IV) was given straight to those who had a score above 28. This questionnaire allowed us to distinguish one group of subjects with BPD and a group with other PD (without BPD). Clinical evaluation included Axis I (MINI), Axis II (SIDP-IV), psychopathological features (YSQ-I, Defense Style Questionnaire (DSQ-40), demographic variables and therapeutic alliance (Haq-II).
  • Other: No intervention
    No intervention
Study Groups/Cohorts
  • Psychiatric patients group
    Patient groups were composed with: BPD, other PD and assessed Psychologic test
    Intervention: Behavioral: Psychologic test
  • Control group
    Matched controls (age, sex) composed the 3rd and 4th group (BPD control and other PD control). They were randomly chosen in the health database insurance previously used. They had no intervention.
    Intervention: Other: No intervention
Publications * Cailhol L, Thalamas C, Garrido C, Birmes P, Lapeyre-Mestre M. [Mental health service utilization among borderline personality disorder patients inpatient]. Encephale. 2015 Apr;41(2):115-22. doi: 10.1016/j.encep.2014.10.008. Epub 2014 Dec 17. French.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: July 12, 2016)
98
Original Estimated Enrollment
 (submitted: July 7, 2016)
400
Actual Study Completion Date June 2010
Actual Primary Completion Date June 2010   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Affiliated with the health insurance
  • Inpatient Psychiatry

Exclusion Criteria:

  • Patient in forced hospitalization
  • chronic psychotic disorder, mania or hypomania state, known mental retardation.
  • Patient does not speak or read French
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 60 Years   (Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT02829658
Other Study ID Numbers 08 120 03
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement
Plan to Share IPD: Undecided
Responsible Party University Hospital, Toulouse
Study Sponsor University Hospital, Toulouse
Collaborators Not Provided
Investigators
Principal Investigator: CAILHOL Lionel, MD University Hospital, Toulouse
PRS Account University Hospital, Toulouse
Verification Date May 2017